PEREGRINE CAPITAL MANAGEMENT LLC
Position in TRVI — Trevi Therapeutics, Inc.
CIK 764529
MINNEAPOLIS, MN
Position in TRVI
as of Jun 30, 2026
· filed Jul 17, 2026
Position Value
$8,286,381
+$1,958,101 QoQ
Shares Held
444,310
-16.2% QoQ
Ownership
0.312%
of shares outstanding
% of Portfolio
0.28%
of 13F equity value
Holder Rank
#54
of 216 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 37%
Shared 0%
None 63%
Common Shares in TRVI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PEREGRINE CAPITAL MANAGEMENT LLC holds $166,405,812 across 19 Biotechnology names. TRVI ranks #9 (5.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
29,732 | $27,584,457 | |
| 2 | MIRM |
Mirum Pharmaceuticals, Inc.
|
88,820 | $10,398,157 | |
| 3 | XENE |
Xenon Pharmaceuticals Inc.
|
164,894 | $9,953,001 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
162,714 | $9,310,495 | |
| 5 | AXSM |
Axsome Therapeutics, Inc.
|
37,285 | $9,126,249 | |
| 6 | COGT |
Cogent Biosciences, Inc.
|
226,350 | $8,759,745 | |
| 7 | PRAX |
Praxis Precision Medicines, Inc.
|
25,790 | $8,634,234 | |
| 8 | CYTK |
Cytokinetics Inc
|
100,019 | $8,520,618 |
All Filings in TRVI
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,286,381 | 444,310 | Shares | Sole | 2026-07-17 | |
| 2026-03-31 | $6,328,280 | 530,451 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $6,356,216 | 507,685 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $5,677,245 | 620,464 | Shares | Sole | 2025-10-23 | |
| No filing history on record for this holder in this stock. | ||||||